Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital
Santos-Díaz, G.; Pérez-Pico, A.M.; Suárez-Santisteban, M.Á.; García-Bernalt, V.; Mayordomo, R.; Dorado, P. Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital. Pharmaceutics 2020, 12, 713. https://doi.org/10.3390/pharmaceutics12080713
Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, García-Bernalt V, Mayordomo R, Dorado P. Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital. Pharmaceutics. 2020; 12(8):713. https://doi.org/10.3390/pharmaceutics12080713
Chicago/Turabian StyleSantos-Díaz, Gracia, Ana María Pérez-Pico, Miguel Ángel Suárez-Santisteban, Vanesa García-Bernalt, Raquel Mayordomo, and Pedro Dorado. 2020. "Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital" Pharmaceutics 12, no. 8: 713. https://doi.org/10.3390/pharmaceutics12080713